|
| 37498746 | Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL. | | 2023 |
| 37589839 | Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes. | Breast Cancer Res Treat | 2023 |
| 37479706 | Obesity-associated changes in molecular biology of primary breast cancer. | Nat Commun | 2023 |
| 36585450 | Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. | Nat Cancer | 2023 |
| 37433103 | Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP. | J Clin Oncol | 2023 |
| 35017534 | BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1. | Nature Communications | 2022 |
| 36352222 | Spatial genomics maps the structure, nature and evolution of cancer clones. | Nature | 2022 |
| 34376532 | Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma. | Clinical Cancer Research | 2021 |
| 33462368 | Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer. | Mod Pathol | 2021 |
| 32798689 | TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. | Ann Oncol | 2020 |
| 31796517 | Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and <i>BRCA1/2</i> Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. | Clin Cancer Res | 2020 |
| 32249764 | Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. | Nat Commun | 2020 |
| 30988298 | Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation. | Nat Commun | 2019 |
| 31727117 | Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. | | 2019 |
| 30651399 | Exploring Biomarkers of Phosphoinositide 3-Kinase Pathway Activation in the Treatment of Hormone Receptor Positive, Human Epidermal Growth Receptor 2 Negative Advanced Breast Cancer. | Oncologist | 2019 |
| 31300453 | DNA Methylation Markers for Breast Cancer Detection in the Developing World. | Clin Cancer Res | 2019 |
| 29452344 | Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers. | Ann Oncol | 2018 |
| 27959581 | Quality Assurance in Breast Pathology: Lessons Learned From a Review of Amended Reports. | | 2017 |
| 28777143 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. | Adv Anat Pathol | 2017 |
| 28777142 | Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research. | Adv Anat Pathol | 2017 |
| 28346442 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. | Nat Genet | 2017 |
| 28904067 | Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency. | Cancer Res | 2017 |
| 28810143 | Genomic Evolution of Breast Cancer Metastasis and Relapse. | Cancer Cell | 2017 |
| 28329761 | Somatic mutations reveal asymmetric cellular dynamics in the early human embryo. | Nature | 2017 |
| 28874753 | Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer. | Nat Commun | 2017 |
| 28652380 | Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition. | Cancer Discov | 2017 |
| 29055014 | Protein Acyltransferase DHHC3 Regulates Breast Tumor Growth, Oxidative Stress, and Senescence. | Cancer Research | 2017 |
| 29058716 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. | Nat Genet | 2017 |
| 29074948 | Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. | Nat Genet | 2017 |
| 27452521 | Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions. | Oncogene | 2017 |
| 28288110 | HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. | Nat Med | 2017 |
| 27694895 | Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer. | Oncogene | 2017 |
| 27796716 | Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. | Breast Cancer Res Treat | 2017 |
| 28112740 | A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. | Nat Genet | 2017 |
| 27666519 | Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. | Nat Commun | 2016 |
| 27197245 | Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. | Genome Res | 2016 |
| 27111282 | Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles. | Nat Med | 2016 |
| 27136393 | The topography of mutational processes in breast cancer genomes. | Nat Commun | 2016 |
| 27135926 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences. | Nature | 2016 |
| 26957554 | Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. | Clin Cancer Res | 2016 |
| 27368101 | Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine. | Cell | 2016 |
| 26728511 | Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer. | Molecular Cancer | 2016 |
| 27117709 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. | Nat Commun | 2016 |
| 26768026 | Phyllodes tumours of the breast: a consensus review. | Histopathology | 2016 |
| 26348644 | Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management. | Histopathology | 2016 |
| 27615322 | Mutational signatures of ionizing radiation in second malignancies. | Nat Commun | 2016 |
| 27880910 | CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. | Cell Rep | 2016 |
| 27498871 | Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer. | Cell Rep | 2016 |
| 25214542 | The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. | Ann Oncol | 2015 |
| 25963125 | Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. | Genome Res | 2015 |